approval · primary record
ETEPLIRSEN
FDA · NDA · 2024-12-27
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2024-12-27 |
| Brand | EXONDYS 51 |
| Sponsor | SAREPTA THERAPS INC |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:30:27.787Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:ETEPLIRSEN:2024-12-27
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.